Prevalence and implications of cytochrome P450 substrates in Massachusetts hospital discharges-Reference-Cited by-同舟云学术

Prevalence and implications of cytochrome P450 substrates in Massachusetts hospital discharges

Published:2016-05-10 Issue:4 Volume:17 Page:382-385
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

McCoy T H,Castro V M,Cagan A,Roberson A M,Perlis R H

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/tpj201624.pdf

Reference18 articles.

1. Office of the Press Secretary 2015. FACT SHEET: President Obama’s Precision Medicine Initiative. In: Statements and Releases. The White House.

2. IOM (Institute of Medicine). Policy issues in the development of personalized medicine in oncology. In: M Patlak, L Levit (eds). Workshop Summary.. National Academies Press: Washington, DC, 2010.

3. Zhou SF, Liu JP, Chowbay B . Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009; 41: 89–295.

4. Wienkers L, Heath T . Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005; 4: 825–833.

5. Wang L, McLeod HL, Weinshilboum RM . Genomics and drug response. N Engl J Med 2011; 364: 1144–1153.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stratified delirium risk using prescription medication data in a state-wide cohort;General Hospital Psychiatry;2021-07

2. Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder;Depression and Anxiety;2020-05-07

3. Utility of human leukocyte antigen-B*58;Pharmacogenetics and Genomics;2019-01

4. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study;Depression and Anxiety;2018-05-07